BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wada E, Onoue T, Kobayashi T, Handa T, Hayase A, Ito M, Furukawa M, Okuji T, Okada N, Iwama S, Sugiyama M, Tsunekawa T, Takagi H, Hagiwara D, Ito Y, Suga H, Banno R, Kuwatsuka Y, Ando M, Goto M, Arima H. Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial. BMJ Open Diabetes Res Care 2020;8:e001115. [PMID: 32518063 DOI: 10.1136/bmjdrc-2019-001115] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Beck RW, Bergenstal RM. Continuous Glucose Monitoring for Type 2 Diabetes: How Does It Compare with Type 1 Diabetes? Diabetes Technol Ther 2021. [PMID: 34569811 DOI: 10.1089/dia.2021.0374] [Reference Citation Analysis]
2 Aggarwal A, Pathak S, Goyal R. Clinical and Economic Outcomes of Continuous Glucose Monitoring System (CGMS) in Patients with Diabetes Mellitus: A Systematic Literature Review. Diabetes Research and Clinical Practice 2022. [DOI: 10.1016/j.diabres.2022.109825] [Reference Citation Analysis]
3 Di Molfetta S, Bosi E, Ceriello A, Cucinotta D, Tiengo A, Scavini M, Piccolo C, Bonizzoni E, Acmet E, Giorgino F; PRISMA STUDY GROUP. Structured self-monitoring of blood glucose is associated with more appropriate therapeutic interventions than unstructured self-monitoring: A novel analysis of data from the PRISMA trial. Diabetes Res Clin Pract 2021;181:109070. [PMID: 34592390 DOI: 10.1016/j.diabres.2021.109070] [Reference Citation Analysis]
4 Al Hayek A, Al Dawish M, El Jammal M. The Impact of Flash Glucose Monitoring on Markers of Glycaemic Control and Patient Satisfaction in Type 2 Diabetes. Cureus 2021;13:e16007. [PMID: 34354874 DOI: 10.7759/cureus.16007] [Reference Citation Analysis]
5 Dehghani Zahedani A, Shariat Torbaghan S, Rahili S, Karlin K, Scilley D, Thakkar R, Saberi M, Hashemi N, Perelman D, Aghaeepour N, McLaughlin T, Snyder MP. Improvement in Glucose Regulation Using a Digital Tracker and Continuous Glucose Monitoring in Healthy Adults and Those with Type 2 Diabetes. Diabetes Ther 2021;12:1871-86. [PMID: 34047962 DOI: 10.1007/s13300-021-01081-3] [Reference Citation Analysis]
6 Wright EE, Subramanian S. Evolving Use of Continuous Glucose Monitoring Beyond Intensive Insulin Treatment. Diabetes Technol Ther 2021;23:S12-8. [PMID: 34546082 DOI: 10.1089/dia.2021.0191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Cowart K, Updike WH, Franks R. Continuous glucose monitoring in persons with type 2 diabetes not using insulin. Expert Rev Med Devices 2021;18:1049-55. [PMID: 34633261 DOI: 10.1080/17434440.2021.1992274] [Reference Citation Analysis]
8 Glennie JL, Berard L, Levrat-guillen F. Sensor-Based Technology: Bringing Value to People with Diabetes and the Healthcare System in an Evolving World. CEOR 2022;Volume 14:75-90. [DOI: 10.2147/ceor.s346736] [Reference Citation Analysis]
9 Faber J, Eldrup E, Selmer C, Pichat C, Hecquet SK, Watt T, Kreiner S, Karpatschof B, Gyntelberg F, Ballegaard S, Gjedde A. Reduction of Pressure Pain Sensitivity as Novel Non-pharmacological Therapeutic Approach to Type 2 Diabetes: A Randomized Trial. Front Neurosci 2021;15:613858. [PMID: 33776633 DOI: 10.3389/fnins.2021.613858] [Reference Citation Analysis]
10 Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, Green J, Huang E, Isaacs D, Kahan S, Leon J, Lyons SK, Peters AL, Prahalad P, Reusch JEB, Young-Hyman D, Das S, Kosiborod M; American Diabetes Association Professional Practice Committee., American Diabetes Association Professional Practice Committee:. 7. Diabetes Technology: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45:S97-S112. [PMID: 34964871 DOI: 10.2337/dc22-S007] [Reference Citation Analysis]
11 Soriano EC, Polonsky WH. The Influence of Real-Time Continuous Glucose Monitoring on Psychosocial Outcomes in Insulin-Using Type 2 Diabetes. J Diabetes Sci Technol 2022;:19322968221094831. [PMID: 35533137 DOI: 10.1177/19322968221094831] [Reference Citation Analysis]
12 Oser TK, Litchman ML, Allen NA, Kwan BM, Fisher L, Jortberg BT, Polonsky WH, Oser SM. Personal Continuous Glucose Monitoring Use Among Adults with Type 2 Diabetes: Clinical Efficacy and Economic Impacts. Curr Diab Rep 2021;21:49. [PMID: 34882273 DOI: 10.1007/s11892-021-01408-1] [Reference Citation Analysis]
13 Di Molfetta S, Rossi A, Assaloni R, Cherubini V, Consoli A, Di Bartolo P, Guardasole V, Laurenzi A, Lombardo F, Maffeis C, Scaramuzza A, Irace C; Working group of Diabetes, Technology AMD-SID-SIEDP. A guide for the use of LibreView digital diabetes platform in clinical practice: Expert paper of the Italian Working Group for Diabetes and Technology. Diabetes Res Clin Pract 2022;:109867. [PMID: 35405166 DOI: 10.1016/j.diabres.2022.109867] [Reference Citation Analysis]
14 Kitae A, Kimura T, Munekawa C, Hosomi Y, Osaka T, Kitagawa N, Ushigome E, Yamazaki M, Hamaguchi M, Fukui M. Development of application to automatically calculate mean amplitude of glycaemic excursions using intermittently scanned continuous glucose monitoring data. Diabetes Obes Metab 2021;23:2155-60. [PMID: 34085376 DOI: 10.1111/dom.14457] [Reference Citation Analysis]